Module 1 - Overview of COPD and Optimal Standard-of-Care Therapy

This module covers the basics of COPD management, including assessment, treatment across the spectrum of disease, and the need for new therapies.

Surya P. Bhatt, MD, MSPH

Professor of Medicine
Division of Pulmonary, Allergy & Critical Care Medicine
University of Alabama at Birmingham

Surya Bhatt, MD, MSPH, is Professor of Medicine and Endowed Professor of Airways Disease in the Division of Pulmonary, Allergy and Critical Care Medicine at the University of Alabama at Birmingham. He is the Director of the UAB Center for Lung Analytics and Imaging Research (CLAIR), and also serves as the Medical Director of the UAB Pulmonary Function Testing and Exercise Physiology Lab, and as Medical Director of the UAB center-based and Telehealth Pulmonary Rehabilitation Programs. 

His primary clinical and research interests are in COPD. He leads 2 research programs: lung imaging and COPD clinical trials. His research is funded by the National Heart, Lung, and Blood Institute (NHLBI) with R01, R21, and UH3 grants. He has developed several new imaging biomarkers for COPD as well as new spirometric methods to detect airflow obstruction. He is the principal investigator of the multicenter TeleCOPD study, funded by the NHLBI. He has more than 240 peer-reviewed publications.
 
Dr. Bhatt has received multiple national and international awards for his research, including the Alfred Soffer Award from the American College of Chest Physicians, the UAB Dean’s Excellence Award for Research, Early Career Achievement Award from the Clinical Problems Assembly of the American Thoracic Society (ATS), the Dr. Linda Hall Innovation Award from the American Association of Cardiovascular and Pulmonary Rehabilitation, the Top Reviewer Award from the American Journal of Respiratory and Critical Care Medicine (AJRCCM) and Annals of the ATS, and most recently was elected member of the American Society of Clinical Investigation. He has authored multiple book chapters, including in Braunwald’s Heart Disease and Murray & Nadel’s Textbook of Respiratory Medicine. He serves as Associate Editor for Annals of the ATS and on the Editorial Board of the AJRCCM.

1.
Identify patients with COPD at increased risk of exacerbations and utilize emerging biomarkers to guide treatment decisions
2.
Recognize the potential future impact of biologics on the treatment guidelines of COPD, and current levels of guideline-discordant care